Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction

Name: Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Published: 2014
License: Public Domain

Novartis Pharmaceuticals · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

chronic-heart-failure

chronic heart failure with reduced ejection fraction, lcz696, chronic heart failure, arni, congestive heart failure (chf), heart failure (hf), acute heart failure syndrome, congestive cardiac failure (ccf), interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction

Related documents